Congenital cardiovascular malformations are the most common birth defect in the US. As increasing numbers of pediatric patients with cardiovascular disease now survive into adulthood, there is a growing recognition that the incidence of residual disease is high and constitutes a substantial health burden to society. The complexity of management strategies in children with complex heart disease and the understanding of the basis of cardiac disease in the young require the development of a new generation of physicians and scientists dedicated to understanding and improving in the care of children with heart disease. Congenital heart disease is multifactorial in etiology with genetic and environmental factors playing a major role. The advent of new approaches in molecular, biochemical and biophysical technology has facilitated the study of the genetic and environmental regulation of cardiac development and disease. Identification of gene defects and the unique molecular pathways that mediate the effects of these genes provides an opportunity to develop diagnostic, preventive and therapeutic strategies tailored to individual I cardiac defects. We propose a 2-3 year program in which postdoctoral trainees in pediatric cardiology will I specialize in basic and translational approaches to cardiovascular development, genetics of cardiac disease, I electrophysiology, biochemistry or molecular biology. We incorporate these training areas because we need to develop a cadre of scientists who can carry the understanding of disease from genetic determinants, through translation, transduction and phenotypic expression. To provide this training, we have recruited to the training faculty individuals with expertise in basic science disciplines. Although no one trainee can be expected to master all the techniques, the program will teach at least one individual discipline in depth to each trainee, and equally importantly, school the individual in interfacing with other disciplines and in translating laboratory findings to the bedside.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL076116-02
Application #
6881096
Study Section
Special Emphasis Panel (ZHL1-CSR-G (F1))
Program Officer
Commarato, Michael
Project Start
2004-07-01
Project End
2009-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
2
Fiscal Year
2005
Total Cost
$114,687
Indirect Cost
Name
Columbia University (N.Y.)
Department
Pediatrics
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Morrow, Jarrett D; Cho, Michael H; Platig, John et al. (2018) Ensemble genomic analysis in human lung tissue identifies novel genes for chronic obstructive pulmonary disease. Hum Genomics 12:1
Sakornsakolpat, Phuwanat; Morrow, Jarrett D; Castaldi, Peter J et al. (2018) Integrative genomics identifies new genes associated with severe COPD and emphysema. Respir Res 19:46
Morrow, Jarrett D; Glass, Kimberly; Cho, Michael H et al. (2018) Human Lung DNA Methylation Quantitative Trait Loci Colocalize with Chronic Obstructive Pulmonary Disease Genome-Wide Association Loci. Am J Respir Crit Care Med 197:1275-1284
Sharma, Amitabh; Kitsak, Maksim; Cho, Michael H et al. (2018) Integration of Molecular Interactome and Targeted Interaction Analysis to Identify a COPD Disease Network Module. Sci Rep 8:14439
Radder, Josiah E; Gregory, Alyssa D; Leme, Adriana S et al. (2017) Variable Susceptibility to Cigarette Smoke-Induced Emphysema in 34 Inbred Strains of Mice Implicates Abi3bp in Emphysema Susceptibility. Am J Respir Cell Mol Biol 57:367-375
Busch, Robert; Hobbs, Brian D; Zhou, Jin et al. (2017) Genetic Association and Risk Scores in a Chronic Obstructive Pulmonary Disease Meta-analysis of 16,707 Subjects. Am J Respir Cell Mol Biol 57:35-46
Morrow, Jarrett D; Zhou, Xiaobo; Lao, Taotao et al. (2017) Functional interactors of three genome-wide association study genes are differentially expressed in severe chronic obstructive pulmonary disease lung tissue. Sci Rep 7:44232
Dodd, James W; Novotny, Paul; Sciurba, Frank C et al. (2015) Executive Function, Survival, and Hospitalization in Chronic Obstructive Pulmonary Disease. A Longitudinal Analysis of the National Emphysema Treatment Trial (NETT). Ann Am Thorac Soc 12:1473-81
Kaplan, Robert M; Sun, Qiankun; Ries, Andrew L (2015) Quality of well-being outcomes in the National Emphysema Treatment Trial. Chest 147:377-387
Benzo, Roberto; Siemion, Wendy; Novotny, Paul et al. (2013) Factors to inform clinicians about the end of life in severe chronic obstructive pulmonary disease. J Pain Symptom Manage 46:491-499.e4

Showing the most recent 10 out of 34 publications